Quick Takeaways
- RXST - RxSight, Inc. has 21 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 21 Insiders of RxSight, Inc.
- Symbol
- RXST on Nasdaq
- Location
- Aliso Viejo, CA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 09 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
RxSight, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| RxSight I, LLC | 10%+ Owner | $96,806,554 | Mixed | 03 Aug 2021 | ||
| Richard M. Wolfen | Director | $88,332,816 | Mixed | 03 Aug 2021 | ||
| Bruce C. Robertson | Director | $66,482,607 | Mixed | 03 Aug 2021 | ||
| Daniel Mark Schwartz | Director | $19,567,301 | Mixed | 03 Aug 2021 | ||
| RA CAPITAL MANAGEMENT, L.P. | 10%+ Owner | $10,265,312 | Mixed | 03 Aug 2021 | ||
| Eric Weinberg | Exhibit 24 - Power of Attorney Chief Business Development Officer | $4,697,521 | Mixed | 27 Feb 2026 | ||
| Jesse Anderson Corley | Director | $928,669 | Mixed | 03 Jun 2025 | ||
| William J. Link PhD | Director | $771,884 | Mixed | 03 Jun 2025 | ||
| Juliet Tammenoms Bakker | Director | $649,002 | Mixed | 03 Jun 2025 | ||
| PALMISANO ROBERT J | Director | $535,969 | Mixed | 03 Jun 2025 | ||
| Robert Keith Warner | Director | $535,969 | Mixed | 03 Jun 2025 | ||
| Julie Andrews | Director | $535,969 | Mixed | 03 Jun 2025 | ||
| Ilya Goldshleger | Chief Operating Officer | $490,047 | Median | 17 Apr 2026 | ||
| Tamara Fountain | Director | $464,217 | Mixed | 03 Jun 2025 | ||
| Raymond W. Cohen | Director | $285,344 | Mixed | 31 Jul 2025 | ||
| Shweta Maniar | Director | $236,843 | Mixed | 03 Jun 2025 | ||
| Shelley B. Thunen | Co-President and Chief Financial Officer | $166,403 | Mixed | 14 Apr 2025 | ||
| Scott Gaines | Chief Customer Officer | $112,993 | Mixed | 27 Feb 2026 | ||
| Mark Wilterding | Chief Financial Officer | $94,158 | Mixed | 28 Feb 2026 | ||
| Christopher Cox | Director | Mixed | 29 Jul 2021 | |||
| Ronald M. Kurtz MD | President & CEO, Director | Mixed | 27 Feb 2026 |
Top shareholders of RxSight, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RxSight I, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,016,778
|
$96,806,554 | — | 03 Aug 2021 | |
| Richard M. Wolfen |
3/4/5
|
Director |
—
class O/S missing
|
1,840,244
|
$88,332,816 | — | 03 Aug 2021 | |
| Bruce C. Robertson |
3/4/5
|
Director |
—
class O/S missing
|
1,385,037
|
$66,482,607 | — | 03 Aug 2021 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.8%
from 13D/G
|
2,705,006
|
$28,186,162 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.4%
|
2,229,539
|
$23,231,797 | — | 31 Dec 2025 | |
| Artisan Partners Limited Partnership |
13F
13D/G
|
Company · Artisan Partners Asset Management Inc. |
5.2%
from 13D/G
|
2,157,264
|
$22,478,691 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
13D/G
|
Company |
5.4%
from 13D/G
|
2,129,038
|
$22,184,576 | — | 31 Dec 2025 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
4.8%
|
2,000,060
|
$20,840,625 | — | 31 Dec 2025 | |
| No Street GP LP |
13F
|
Company |
4.8%
|
1,975,000
|
$20,579,500 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
4.5%
|
1,883,829
|
$19,629,498 | — | 31 Dec 2025 | |
| Daniel Mark Schwartz |
3/4/5
|
Director |
—
class O/S missing
|
407,647
|
$19,567,301 | — | 03 Aug 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3%
|
1,230,853
|
$12,825,488 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.5%
|
1,045,822
|
$10,897,465 | — | 31 Dec 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
213,858
|
$10,265,312 | — | 03 Aug 2021 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
2.4%
|
975,744
|
$10,167,252 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
13D/G
|
Company |
0.4%
from 13D/G
|
928,613
|
$9,676,148 | — | 31 Dec 2025 | |
| Defilade Capital Management, L.P. |
13F
|
Company |
2.2%
|
913,090
|
$9,514,398 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2%
|
848,977
|
$8,846,340 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
2%
|
842,236
|
$8,776,100 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
837,799
|
$8,732,280 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.9%
|
798,359
|
$8,318,901 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.8%
|
765,025
|
$7,971,562 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.8%
|
732,100
|
$7,628,482 | — | 31 Dec 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
1.7%
|
693,146
|
$7,222,581 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
1.5%
|
624,600
|
$6,508,332 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
565,190
|
$5,889,280 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.3%
|
531,730
|
$5,540,627 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
1.1%
|
473,567
|
$4,934,569 | — | 31 Dec 2025 | |
| Eric Weinberg |
3/4/5
|
Exhibit 24 - Power of Attorney Chief Business Development Officer |
—
mixed-class rows
|
528,472
mixed-class rows
|
$4,697,521 | — | 27 Feb 2026 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1%
|
425,649
|
$4,435,263 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1%
|
416,828
|
$4,340,000 | — | 31 Dec 2025 | |
| Grandeur Peak Global Advisors, LLC |
13F
|
Company |
0.94%
|
390,551
|
$4,069,541 | — | 31 Dec 2025 | |
| BROWN CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.86%
|
357,713
|
$3,727,369 | — | 31 Dec 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.85%
|
351,655
|
$3,664,245 | — | 31 Dec 2025 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.72%
|
300,000
|
$3,126,000 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.7%
|
291,014
|
$3,032,366 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.69%
|
287,328
|
$2,993,957 | — | 31 Dec 2025 | |
| Vitruvian Partners LLP |
13F
|
Company |
0.67%
|
278,865
|
$2,905,773 | — | 31 Dec 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
0.63%
|
263,420
|
$2,744,836 | — | 31 Dec 2025 | |
| One Fin Capital Management LP |
13F
|
Company |
0.61%
|
254,583
|
$2,652,755 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.61%
|
252,598
|
$2,632,071 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.57%
|
237,971
|
$2,479,658 | — | 31 Dec 2025 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.53%
|
218,763
|
$2,279,510 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.53%
|
218,672
|
$2,279,159 | — | 31 Dec 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.53%
|
218,675
|
$2,278,591 | — | 31 Dec 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.45%
|
185,121
|
$1,928,961 | — | 31 Dec 2025 | |
| Divisadero Street Capital Management, LP |
13D/G
|
— |
0.5%
|
218,918
|
$1,751,344 | -$18,500,824 | 30 Jun 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.39%
|
163,064
|
$1,699,000 | — | 31 Dec 2025 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.39%
|
162,300
|
$1,691,166 | — | 31 Dec 2025 | |
| Carnegie Lake Advisors LLC |
13F
|
Company |
0.39%
|
161,845
|
$1,686,425 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for RxSight, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Ilya Goldshleger | RXST | Common Stock | Options Exercise | 19% | 12,489 | 78,180 | 17 Apr 2026 | Direct | ||
| Ilya Goldshleger | RXST | Stock Option (right to buy) | Options Exercise | -100% | -12,489 | 5 | 17 Apr 2026 | Direct | ||
| Mark Wilterding | RXST | Common Stock | Tax liability | -39.5% | -8,068 | 12,373 | 28 Feb 2026 | Direct | ||
| Mark Wilterding | RXST | Common Stock | Options Exercise | 20,441 | 20,441 | 28 Feb 2026 | Direct | |||
| Mark Wilterding | RXST | Restricted Stock Unit | Options Exercise | -12.5% | -20,441 | 143,087 | 28 Feb 2026 | Direct | ||
| Scott Gaines | RXST | Common Stock | Tax liability | -14.8% | -2,580 | 14,848 | 28 Feb 2026 | Direct | ||
| Scott Gaines | RXST | Common Stock | Options Exercise | 56.1% | 6,261 | 17,428 | 28 Feb 2026 | Direct | ||
| Scott Gaines | RXST | Restricted Stock Unit | Options Exercise | -72.2% | -6,261 | 2,414 | 28 Feb 2026 | Direct | ||
| Scott Gaines | RXST | Restricted Stock Unit | Award | 32,218 | 32,218 | 27 Feb 2026 | Direct | |||
| Ilya Goldshleger | RXST | Restricted Stock Unit | Award | 32,218 | 32,218 | 27 Feb 2026 | Direct | |||
| Eric Weinberg | RXST | Restricted Stock Unit | Award | 32,218 | 32,218 | 27 Feb 2026 | Direct | |||
| Ronald M. Kurtz MD | RXST | Restricted Stock Unit | Award | 80,545 | 80,545 | 27 Feb 2026 | Direct | |||
| Mark Wilterding | RXST | Restricted Stock Unit | Award | 163,528 | 163,528 | 12 Jan 2026 | Direct | |||
| Mark Wilterding | RXST | Stock Option (right to buy) | Award | 258,770 | 258,770 | 12 Jan 2026 | Direct | |||
| Ilya Goldshleger | RXST | Common Stock | Options Exercise | 55.5% | 23,445 | 65,691 | 25 Sep 2025 | Direct | ||
| Ilya Goldshleger | RXST | Stock Option (right to buy) | Options Exercise | -100% | -23,445 | 0 | 25 Sep 2025 | Direct | ||
| Raymond W. Cohen | RXST | Common Stock | Award | 35,668 | 35,668 | 31 Jul 2025 | Direct | |||
| William J. Link PhD | RXST | Common Stock | Award | 39.7% | 10,752 | 37,855 | 03 Jun 2025 | Direct | ||
| Tamara Fountain | RXST | Common Stock | Award | 43.4% | 10,752 | 35,545 | 03 Jun 2025 | Direct | ||
| Robert Keith Warner | RXST | Common Stock | Award | 35.5% | 10,752 | 41,039 | 03 Jun 2025 | Direct | ||
| Shweta Maniar | RXST | Common Stock | Award | 145.6% | 10,752 | 18,135 | 03 Jun 2025 | Direct | ||
| Palmisano Robert J | RXST | Common Stock | Award | 35.5% | 10,752 | 41,039 | 03 Jun 2025 | Direct | ||
| Julie Andrews | RXST | Common Stock | Award | 35.5% | 10,752 | 41,039 | 03 Jun 2025 | Direct | ||
| Bakker Juliet Tammenoms | RXST | Common Stock | Award | 28.8% | 10,752 | 48,146 | 03 Jun 2025 | Direct | ||
| Jesse Anderson Corley | RXST | Common Stock | Award | 28% | 10,752 | 49,190 | 03 Jun 2025 | Direct | ||
| Eric Weinberg | RXST | Common Stock | Options Exercise | 2558.2% | 188,002 | 195,351 | 02 Jun 2025 | Direct | ||
| Eric Weinberg | RXST | Stock Option (right to buy) | Options Exercise | -100% | -188,002 | 0 | 02 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.